Oncoblast vs Treating SR

The OncoBlast™ app, created by the Binaytara, offers a unique gaming experience for hematology and oncology providers. This app allows medical professionals in hematology and oncology to engage in educational games, enabling them to earn continuing education credits while playing. OncoBlast™ is available at no cost and provides interactive, real-time feedback to enhance learning experiences for providers. Binaytara is a non-profit organization dedicated to improving healthcare outcomes through advocacy, education, and innovation. Founded with a vision to create a significant impact in the healthcare sector, Binaytara focuses on addressing gaps in medical knowledge and practice, especially in the fields of hematology and oncology. Their commitment to education and training extends beyond traditional methods, embracing technology and interactive platforms to reach a broader audience of healthcare professionals. This app, OncoBlast™, takes us one step closer towards this commitment.

Dive into an immersive and engaging learning experience that covers the latest clinical data for targeted therapies, provides expert guidance on integrating them into patient specific treatment plans, including sequencing strategies to maximize outcomes and long-term management with the goal of improving quality of life; ameliorating symptoms; and reducing mortality rates. Learners will have the opportunity to explore key differences in the mechanisms that approved therapies for SR-cGVHD employ to target the inflammatory and fibrotic pathophysiological presentations that drive this condition and impair patient health. These insights will help guide clinicians with effective treatment selection and sequencing.